Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

What to Expect From Pfizer Earnings

When talking about the pharmaceutical industry, Pfizer Inc. (NYSE: PFE) is bound to come up, even more so with its second-quarter earnings just around the corner. This mega-pharma has been attacking M&A over the past year, winning some decisive battles and losing some as well, but ultimately ending up with a very strong pipeline regardless. This earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give some insight into what companies it may be looking to pursue next.

The consensus estimates from Thomson Reuters are $0.62 in earnings per share (EPS) on $13.01 billion in revenue. In the same period of last year, Pfizer reported EPS of $0.56 and $11.85 billion in revenue.

This top pharmaceutical company recently...